Results 181 to 190 of about 276,079 (291)
Linking Biochemistry, Vascular Biology, and Clinical Events in Acute Coronary Syndromes
Richard C. Becker, Annemarie Armani
openalex +1 more source
ABSTRACT Background Psoriasis is a chronic immune‐mediated inflammatory disease with a global prevalence of 2%–3% and 1.3% in Brazil. It is associated with comorbidities such as obesity, hypertension, and diabetes, all of which contribute to increased cardiovascular risk due to systemic inflammation and endothelial dysfunction.
Tiago A. S. Costa +2 more
wiley +1 more source
Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome. [PDF]
Galli M, Gragnano F, Valgimigli M.
europepmc +1 more source
In a 12‐week randomized trial of 159 psoriasis patients, educational messages and treatment reminders delivered through Facebook improved treatment adherence, reduced disease severity, and enhanced quality of life. Three times‐weekly messages provided the greatest benefits, including superior adherence, clearer skin, and higher patient satisfaction ...
Jennifer Lavina T. Ngo +1 more
wiley +1 more source
Allergy to acetylsalicylic acid among patients with acute coronary syndrome. [PDF]
Haddad A, Mir A, Copaescu AM.
europepmc +1 more source
Acute leukemia presenting as acute coronary syndrome: A rare case report
Venkat Raghavan A.T.M +4 more
openalex +1 more source
ABSTRACT Acute coronary syndrome (ACS) is a clinical syndrome involving myocardial ischemia. This study aimed to elucidate the mechanism of TET3 in ACS‐induced CMEC damage, thereby identifying a new target for ACS treatment. The expression of TET3 in ACS patients and healthy subjects was analyzed.
Jun‐Cheng Liu +5 more
wiley +1 more source
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao +7 more
wiley +1 more source
Metabolic Dysfunction‐Associated Steatotic Liver Disease After Hepatitis C Virus Cure
ABSTRACT Hepatitis C virus (HCV) infection is an infectious disease carrying a high risk of metabolic disorders. Chronic HCV (CHC) patients can possess extrahepatic manifestations such as diabetes, steatotic liver disease (SLD), and other metabolic alterations.
Chung‐Feng Huang +3 more
wiley +1 more source

